Back
Spero Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
SPRO
Spero Therapeutics
Last Price:
1.14
Seasonality Move:
-0.73%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing slight buying pressure.
Spero Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.23 | Sell |
| 50-day SMA: | 1.26 | Sell |
| 200-day SMA: | 1.42 | Sell |
| 8-day EMA: | 1.16 | Sell |
| 20-day EMA: | 1.2 | Sell |
| 50-day EMA: | 1.25 | Sell |
| 200-day EMA: | 1.37 | Sell |
Spero Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 37.1 | Sell |
| Chaikin Money Flow: | 47493 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.17 - 1.31) | Sell |
| Bollinger Bands (100): | (1.22 - 1.38) | Sell |
Spero Therapeutics Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Spero Therapeutics Stock
Is Spero Therapeutics Stock a Buy?
- Spero Therapeutics share price is 1.14 while SPRO 8-day simple moving average is 1.16, which is a Sell signal.
- The stock price of SPRO is 1.14 while Spero Therapeutics 20-day SMA is 1.23, which makes it a Sell.
- Spero Therapeutics 50-day simple moving average is 1.26 while SPRO share price is 1.14, making it a Sell technically.
- SPRO stock price is 1.14 and Spero Therapeutics 200-day simple moving average is 1.42, creating a Sell signal.
SPRO Technical Analysis vs Fundamental Analysis
Sell
16
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy or a Sell?
-
Spero Therapeutics stock is rated a Sell
The current Spero Therapeutics [SPRO] share price is $1.14. The Score for SPRO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Spero Therapeutics Stock Info
Market Cap:
62.15M
Price in USD:
1.14
Share Volume:
94.99K
Spero Therapeutics 52-Week Range
52-Week High:
1.89
52-Week Low:
1.01
Sell
16
Spero Therapeutics (SPRO)
is a Sell
Spero Therapeutics Share Price Forecast
-
What is the Spero Therapeutics stock price today?
The Spero Therapeutics stock price is 1.14 USD today. -
Will SPRO stock go up or go down?
Spero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Spero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spero Therapeutics is overvalued.
Is Spero Therapeutics Stock a Buy?
- Spero Therapeutics share price is 1.14 while SPRO 8-day exponential moving average is 1.16, which is a Sell signal.
- The stock price of SPRO is 1.14 while Spero Therapeutics 20-day EMA is 1.20, which makes it a Sell.
- Spero Therapeutics 50-day exponential moving average is 1.25 while SPRO share price is 1.14, making it a Sell technically.
- SPRO stock price is 1.14 and Spero Therapeutics 200-day simple moving average is 1.37, creating a Sell signal.
Fundamental Analysis of Spero Therapeutics
Is Spero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and an increase next year of $0.58 per share.
Technical Analysis of Spero Therapeutics
Should I short Spero Therapeutics stock?
- SPRO Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Spero Therapeutics is a Sell
- Spero Therapeutics Relative Strength Index (RSI) is 37.1, which suggest Spero Therapeutics is oversold
- The Bollinger Bands (25) for Spero Therapeutics is (1.17 - 1.31), which suggest Spero Therapeutics is a Sell
- The Bollinger Bands (100) for Spero Therapeutics is (1.22 - 1.38), which suggest Spero Therapeutics is a Sell
* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.